Cereblink

Cereblink (Hangzhou) Technology Co., Ltd. was established in early 2021, jointly funded by the listed company Innovation Medical and a scientific research team. The company is dedicated to the research and development of brain-computer interface-related technologies, the transformation of scientific achievements, and external commercial cooperation. Focusing on the core technology development of brain-computer interfaces and pan-brain application medical devices, the company addresses social issues related to the treatment and rehabilitation of stroke, which has a high incidence and high disability rate in international clinical settings. Cereblink develops new brain-computer interface technologies aimed at improving patients' rehabilitation outcomes, maximizing functional recovery, and enhancing their ability to live independently.